Rays of Belief to review September results on November 12

Rays of Belief Limited will consider unaudited results for the quarter and half year ended September 30, 2026, at its November 12 board meeting, following consolidated operating income of ₹25.31 crore in the June 2026 quarter. The agenda covers standalone and consolidated accounts, and the trading window is scheduled to remain closed until November 14.

When will Rays of Belief review its September-quarter results?

Rays of Belief will hold a board meeting on November 12, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company informed the National Stock Exchange of India Limited and BSE Limited about the proposed meeting through a regulatory filing.

The announcement is significant because the September quarter will be the first half-year reporting period after the company completed the acquisition of City Pro Group Inc. The board meeting notice does not provide financial guidance, business targets, or a date for a presentation to investors. It only states that the directors will consider the unaudited results and related half-year accounts.

Rays of Belief had previously convened a board meeting on September 28, 2026, for approval of unaudited standalone and consolidated results for the quarter ended June 30, 2026. The company said the board approved those results along with the limited review report.

What did Rays of Belief report for the June 2026 quarter?

Rays of Belief reported consolidated total income from operations of ₹25.31 crore for the quarter ended June 2026, while total expenses were ₹21.37 crore. Employee cost stood at ₹10.84 crore, and consolidated net profit for the period was ₹2.79 crore, according to the quarterly-results information provided.

The same material contains a separate standalone comparison that reported sales of ₹12.49 crore and net profit of ₹1.42 crore for the June 2026 quarter. These figures should not be compared directly with the consolidated numbers because the reporting bases differ. Consolidated accounts include the financial performance of subsidiaries, while standalone accounts reflect the parent company.

The standalone comparison said sales increased 27.32% from ₹9.81 crore in the June 2025 quarter to ₹12.49 crore in the June 2026 quarter. It also said standalone net profit improved from a loss of ₹0.56 crore in the year-earlier period to a profit of ₹1.42 crore. No share-price movement or market reaction was provided in the source material.

Why is the trading window closed until November 14?

Rays of Belief said its trading window for dealing in company securities would remain closed until November 14, 2026, following the results meeting. The restriction was first communicated as beginning on October 1 and continuing until 48 hours after declaration of the unaudited results for the September quarter and half year.

Trading-window closures are used to restrict dealing by designated persons when they may have access to unpublished price-sensitive information, including financial results. The filing does not indicate any separate corporate event behind the closure. It is connected to the process of finalising and disclosing the September-quarter accounts.

The company also submitted a compliance certificate dated October 26, 2026, for the quarter ended September 30. The filing confirmed compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with Kfin Technologies Limited acting as registrar and share transfer agent.

How does the City Pro Group acquisition fit Rays of Belief's plans?

Rays of Belief disclosed that it completed the acquisition of City Pro Group Inc. for USD 2 million in cash, effective September 18, 2026. The acquired United States business specialises in pediatric developmental care, according to the material provided with the June-quarter results disclosures.

Management described the transaction as a step to expand pediatric services in the United States and create a two-way India-US clinical knowledge exchange. It said it would evaluate integration practices that could be implemented across its India network, which was described as having 136 centres.

The company has indicated that India remains its core growth market and that proceeds are intended to support expansion of its centre network across the country. However, it has not disclosed quantified expansion targets, a timetable for new centres, or a financial contribution forecast from City Pro Group. The September-quarter results may provide investors with further information on consolidation and integration, but the board-meeting notice itself gives no such details.

A separate results summary in the supplied material lists September-quarter revenue of ₹253.14 crore, EBITDA of ₹50.77 crore and net profit of ₹27.87 crore. However, the regulatory notices cited in the same material describe the November 12 meeting as one to consider and approve the September-quarter results. Investors should therefore rely on the final exchange filing and approved financial statements for confirmed results and comparable financial data.

Conclusion

The immediate confirmed event is Rays of Belief's November 12 board meeting for unaudited standalone and consolidated September-quarter and half-year results. The June-quarter consolidated data showed ₹25.31 crore in operating income and ₹2.79 crore in net profit, while the company has also moved ahead with a USD 2 million acquisition to add a US pediatric developmental-care business.

The next disclosures to watch are the board-approved September-quarter results, the limited review report, and any clarification on the financial consolidation of City Pro Group. Investors may also monitor whether Rays of Belief provides a timeline for applying US clinical practices across its stated 136-centre India network or specifies its planned domestic expansion.